| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 11/24/1992 | US5166139 Antiinflammatory agents |
| 11/24/1992 | US5166134 Nasal administration of serine protease inhibitor such as antitrypsin and antichymotrypsin |
| 11/24/1992 | US5165994 Spontaneous equilbrium surfactant vesicles |
| 11/24/1992 | US5165937 Controlled release tablets containing flavoxate |
| 11/24/1992 | US5165935 Cosmetic or dermatological composition, containing kola extracts and method for treatment of cellulitis |
| 11/24/1992 | US5165918 Antimicrobial ophthalmic solutions containing dodecyl-dimethyl-(2 phenoxyethyl)-ammonium bromide and methods of using the same |
| 11/24/1992 | US5165913 Dental floss with surfactants, silicones and drugs |
| 11/24/1992 | CA1310584C Spheroids |
| 11/21/1992 | CA2068980A1 Diltiazem formulation |
| 11/19/1992 | EP0514208A1 Non-stinging measles-mump-rubella vaccine composition |
| 11/19/1992 | EP0514009A1 Corneal treatment agents |
| 11/19/1992 | EP0514008A1 Pharmaceutical preparations based on gastrointestinal mucosa-adherent matrixes or coatings |
| 11/19/1992 | EP0513878A2 Pharmaceutical compositions containing cationic surfactants |
| 11/19/1992 | EP0513861A1 Vaccine adjuvant comprising a tetra-polyol |
| 11/19/1992 | EP0513832A1 Use of dibutyl adipate and isopropyl myristate in topical and transdermal products |
| 11/19/1992 | EP0513400A1 Use of 2-ethoxy benzoic acid for the manufacture of a medicament as analgesic, antipyretic, and/or antiphlogistic |
| 11/19/1992 | EP0513127A1 Propellant compositions. |
| 11/19/1992 | EP0513120A1 Device for detecting vibratory disturbances in living human organs or tissue |
| 11/19/1992 | EP0513104A1 USE OF AN -g(a)-TOCOPHEROL PHOSPHATE OR A DERIVATIVE THEREOF FOR PREPARING COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITIONS, AND COMPOSITIONS THEREBY OBTAINED. |
| 11/19/1992 | EP0513099A1 Novel vehicle gases and their use in medical preparations |
| 11/19/1992 | EP0513035A1 Process for the preparation of azo- and/or disulfide-containing polymers. |
| 11/19/1992 | DE4205943A1 Halogenkohlenwasserstofffreie retardlackloesung fuer pharmazeutische zubereitungen Halocarbon Free Delayed-release coating for pharmaceutical preparations |
| 11/19/1992 | DE4115849A1 Penetrationsfoerdernde substanz Penetrationsfoerdernde substance |
| 11/18/1992 | CN1066270A Pharmaceutical compounds |
| 11/18/1992 | CN1066192A Pulmonary administration of granulocyte colony stimulating factor |
| 11/18/1992 | CN1066186A Pharmaceutical formulation containing dirithromycin |
| 11/18/1992 | CN1066185A Multi-function capsules for poultry influenza |
| 11/18/1992 | CN1066184A Optimized tablet formulation |
| 11/18/1992 | CN1066183A Convertible microemulsion formulations |
| 11/18/1992 | CN1019075B Microemulsion consisting perfluoro-polyether |
| 11/18/1992 | CA2068742A1 Non-stinging vaccine composition |
| 11/17/1992 | WO1992020323A1 Methods for the administration of drugs |
| 11/17/1992 | US5164488 Formation of liposome dispersion |
| 11/17/1992 | US5164405 Cardiovascular |
| 11/17/1992 | US5164380 Improved solubility and pharmacokinetic properties |
| 11/17/1992 | US5164366 Diabetes |
| 11/17/1992 | US5164195 Method of oral delivery with an adherent controlled-release salt sensitive capsule |
| 11/17/1992 | US5164194 Treatment of irritated eye and nose mucous membranes resulting from a cold or allergy |
| 11/17/1992 | US5164193 Sustained-release tablet |
| 11/17/1992 | US5164192 Effervescent composition for oral rehydration |
| 11/17/1992 | US5164191 Lipid vesicles having an alkyd as a wall-forming material |
| 11/17/1992 | US5164190 Hydrophobic drugs, steroids |
| 11/17/1992 | US5164189 Single layer transdermal drug administration system |
| 11/17/1992 | US5164188 Biodegradable ocular implants |
| 11/17/1992 | US5164186 Anticancer agent absorbed on porous calcium hydroxyapatite particles |
| 11/17/1992 | US5164182 Skin lightening, antiinflammatory, cosmetics |
| 11/17/1992 | US5164139 Method for drying wetted molded product |
| 11/17/1992 | US5164014 For drugs |
| 11/17/1992 | CA2102235A1 Method for the administration of drugs |
| 11/17/1992 | CA2067314A1 Low solubility drug-coated bead compositions thereof |
| 11/17/1992 | CA1310272C Ibuprofen sustained release matrix and process |
| 11/17/1992 | CA1310270C Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or salt thereof |
| 11/17/1992 | CA1310268C Transdermal fertility control system and process |
| 11/17/1992 | CA1310264C Modified antibodies for enhanced clearance |
| 11/17/1992 | CA1310242C Controlled release device for an active substance |
| 11/16/1992 | WO1992020378A1 Penetration-promoting substance |
| 11/15/1992 | WO1992020325A1 Engineering the local inflammatory response as a means of controlled release drug delivery |
| 11/15/1992 | CA2103045A1 Engineering the local inflammatory response as a means of controlled release drug delivery |
| 11/14/1992 | WO1992020370A1 Liposomal polysaccharide vaccines |
| 11/14/1992 | CA2109316A1 Liposomal polysaccharide vaccines |
| 11/12/1992 | WO1992019451A1 Method and apparatus for forming a transdermal drug device |
| 11/12/1992 | WO1992019320A1 Magnetically influenced homeopathic pharmaceutical formulations |
| 11/12/1992 | WO1992019283A1 Method of producing zero-order controlled-release devices |
| 11/12/1992 | WO1992019271A1 Percutaneous administration and absorption promoter composition and external preparation for percutaneous administration |
| 11/12/1992 | WO1992019263A1 Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres |
| 11/12/1992 | WO1992019243A1 Liposomal prostaglandin formulations |
| 11/12/1992 | WO1992019242A1 Free amine benzophenanthridine alkaloid compositions |
| 11/12/1992 | WO1992019228A1 Optimized tablet formulation |
| 11/12/1992 | WO1992019227A2 Pharmaceutical formulations |
| 11/12/1992 | WO1992019226A1 A controlled, sustained release delivery system for treating drug dependency |
| 11/12/1992 | WO1992019225A1 Method for improving the therapeutic efficiency of liposoluble antifungal agents from the imidazole family, and composition for implementing same |
| 11/12/1992 | WO1992019209A2 Taste-masked medicaments and their preparation |
| 11/12/1992 | WO1992019195A1 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
| 11/12/1992 | WO1992019183A2 Polymers capable of baromechanical and barochemical transduction |
| 11/12/1992 | DE4212132A1 Propolisbestandteile enthaltendes feststoffprodukt, seine herstellung und verwendung Propolis-containing solid product, its production and use |
| 11/11/1992 | WO1992020851A1 Sewing machine needle and method of manufacturing same |
| 11/11/1992 | EP0512916A2 Liposomal prostaglandin formulations |
| 11/11/1992 | EP0512693A1 Preparation of diagnostic agents |
| 11/11/1992 | EP0512547A1 Pain controlling composition and method of preparation |
| 11/11/1992 | EP0512292A2 Composition for disclosing dental plaque containing cobalamin |
| 11/11/1992 | EP0512107A1 Storage phosphor cassette assembly |
| 11/11/1992 | EP0512104A1 Stabilized hexahydro-5-pyrimidinamine compounds in aqueous solution and methods for preparing same |
| 11/11/1992 | EP0512095A1 Methyl pyrrolidinone chitosan, production process and uses thereof. |
| 11/11/1992 | EP0512050A1 Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| 11/11/1992 | EP0409862B1 Topical preparations |
| 11/11/1992 | EP0406315B1 Controlled release composition |
| 11/11/1992 | EP0190255B1 Erodible matrix for sustained release bioactive composition |
| 11/11/1992 | CA2068366A1 Microcapsule composition and process |
| 11/10/1992 | US5162581 Antitumor and immunosuppressive agents |
| 11/10/1992 | US5162410 Transdermal drug delivery |
| 11/10/1992 | US5162377 Transparent composition |
| 11/10/1992 | US5162335 Di- and tetrahydroisoquinoline derivatives |
| 11/10/1992 | US5162117 Controlled release flutamide composition |
| 11/10/1992 | US5162116 Intra-ruminal device for delivering drugs |
| 11/10/1992 | US5162115 Antineoplastic solution and method for treating neoplasms |
| 11/10/1992 | US5162114 Bone collagen matrix for xenogenic implants |
| 11/10/1992 | US5162110 Sustained release composition |
| 11/10/1992 | US5162057 Coatings for stable sustained release preparations |
| 11/10/1992 | US5162037 Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration |
| 11/10/1992 | CA1309951C Press coated dhp tablets |